{"schema_version":"secwatch.filing_event.v1","accession":"0000950123-24-005877","form_type":"8-K","ticker":"CRSP","cik":"0001674416","company_name":"CRISPR Therapeutics AG","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.527421+00:00","generated_at":"2026-06-01T09:14:34.739034+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"CRISPR Therapeutics appoints Julianne Bruno as COO effective May 23, 2024","bullets":["Bruno previously SVP and Head of Programs & Portfolio; led hemoglobinopathy partnership with Vertex.","Annual salary of $460,000, target bonus 45% of base, and eligible for equity plans.","Received one-time grant of 20,000 RSUs vesting over 4 years (25% annually).","Employment agreement provides 6-month notice period; 12-month notice and accelerated vesting after change in control.","Bruno holds MBA from Wharton, AB from Princeton; prior McKinsey biotech practice leader."],"urls":{"canonical":"https://secwatch.observer/filing/0000950123-24-005877","json":"https://secwatch.observer/filing/0000950123-24-005877.json","markdown":"https://secwatch.observer/filing/0000950123-24-005877.md","text":"https://secwatch.observer/filing/0000950123-24-005877.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674416/000095012324005877/0000950123-24-005877-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674416/000095012324005877/crsp-20240523.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:14:34.739034+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"83bc72861f","claim":"Julianne Bruno was appointed as Chief Operating Officer at CRISPR Therapeutics AG.","evidence_excerpt":"On May 23, 2024, CRISPR Therapeutics AG (the “Company”) announced the promotion of Julianne Bruno, currently the Company’s Senior Vice President and Head of Programs & Portfolio, to be the Company’s Chief Operating Officer effective as of May 23, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674416/000095012324005877/0000950123-24-005877-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Operating Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}